Story available to Subscribers Only

This story is presently only available to logged-in subscribers. Please login or contact sales@ctfn.news to learn about CTFN subscription options.



featured

Ken Wolter / Shutterstock.com

Small Divestiture Possible in C.R. Bard/Becton Dickinson Deal

Becton, Dickinson received a second request for additional information from the Federal Trade Commission on June 9 regarding its pending acquisition of C.R. Bard. The second request is notfeatured

CFIUS Prospects for Lattice Semiconductor/Canyon Bridge Deal Difficult

Lattice Semiconductor and Canyon Bridge Capital mutually withdrew and immediately refiled their joint voluntary notice to the Committee on Foreign Investments in the United States onfeatured

Delrahim Vote Expected to be Positive for Time Warner/AT&T

The October 2016 announced Time Warner/AT&T merger is plodding through the Department of Justice’s investigation and remains on track to close by year’s end, antitrust sourcesfeatured

Genworth/Oceanwide Deal Moving Slowly Towards Approvals

State regulatory reviews of China Oceanwide’s $2.7 billion acquisition of Genworth continue, though the reviews have been slowed by the amount of information beingfeatured

Spectranetics Nearing Expected FDA Approval of Stellarex

Spectranetics Corp. is expected to receive Food and Drug Administration approval this summer for its drug-coated balloon catheter used to treat peripheral artery disease (PAD), makingfeatured

Rite Aid and Walgreens Waiting on FTC Commissioners

An attorney who previously worked with a third party in the merger of Rite Aid and Walgreens Boots Alliance told CTFN that the Federal Trade Commission has ramped up its resourcesfeatured

Ken Wolter / Shutterstock.com

PPG’s Request for Extension of Akzo Offer Deadline Likely to Fail

PPG’s request for an extension of the June 1 deadline to submit a formal offer for AkzoNobel, or face a six-month prohibition on making an offer, is likely to be rejected, threefeatured

Valspar/Sherwin Williams Remedy Package Judged Sufficient by Sources

The Valspar/Sherwin-Williams merger will be approved by the Federal Trade Commission, with a remedy package along the lines of the divestiture to Axalta that Sherwin previouslyfeatured

Akzo Confident in Refuting Shareholder Arguments in Court

Akzo Nobel is confident that the Enterprise Chamber in Amsterdam on Monday will find that it acted correctly in not granting the request for an extraordinary shareholders meeting fromfeatured

X

Interested in a trial?

Simply fill out the form below and one of our representatives will be in touch.